Hamburg - Delayed Quote EUR

Roche Holding AG (RHO.HM)

Compare
245.20
0.00
(0.00%)
As of June 28 at 3:40:45 PM GMT+2. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for RHO.HM

Recent News: RHO.HM

View More
Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results
The Wall Street Journal yesterday
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2024 results with 7% sales growth; fourth quarter marks third straight quarter of 9% growth

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2024 results with 7% sales growth; fourth quarter marks third straight quarter of 9% growth
GlobeNewswire yesterday
Change to the Roche Enlarged Corporate Executive Committee

Change to the Roche Enlarged Corporate Executive Committee
GlobeNewswire 2 days ago
Roche’s Itovebi demonstrated statistically significant and clinically meaningful overall survival benefit in a certain type of HR-positive advanced breast cancer

Roche’s Itovebi demonstrated statistically significant and clinically meaningful overall survival benefit in a certain type of HR-positive advanced breast cancer
GlobeNewswire 3 days ago
Genentech’s Itovebi Demonstrated Statistically Significant and Clinically Meaningful Overall Survival Benefit in a Certain Type of HR-Positive Advanced Breast Cancer

Genentech’s Itovebi Demonstrated Statistically Significant and Clinically Meaningful Overall Survival Benefit in a Certain Type of HR-Positive Advanced Breast Cancer
Business Wire 3 days ago
Roche announces new results from EMBARK demonstrating significant sustained benefits of Elevidys in ambulatory individuals with Duchenne muscular dystrophy (DMD)

Roche announces new results from EMBARK demonstrating significant sustained benefits of Elevidys in ambulatory individuals with Duchenne muscular dystrophy (DMD)
GlobeNewswire 4 days ago
Stocks to watch this week: ASML, Intel, LVMH, Shell and Glencore

Stocks to watch this week: ASML, Intel, LVMH, Shell and Glencore
Yahoo Finance UK 6 days ago
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care

Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
GlobeNewswire 9 days ago
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma

Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
PR Newswire 18 days ago
Roche's momentum in digital pathology continues with FDA clearance on its high-volume slide scanner

Roche's momentum in digital pathology continues with FDA clearance on its high-volume slide scanner
PR Newswire 22 days ago
Roche purchases shares in tender offer for Poseida Therapeutics, Inc.

Roche purchases shares in tender offer for Poseida Therapeutics, Inc.
GlobeNewswire 23 days ago
View More